In this study, however, relatively low dose IL-2 (100 IU/ml) was used, some of the experiments used pure Vγ2Vδ2 T cells omitting accessory cells or used both IL-2 and IL-15, and the cells were not tested for their in vivo tumor activity [87]. The gene discussed is IL15; the disease is neoplasm.